Trial intelligence / Profile preview

Efficacy of oral gabapentin on pain intensity in patients with acute low back pain

IRCT201303096480N4Phase 3Completed

Sponsor
Shahrekord University of Medical Sciences
Start
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of gabapentin in acute lumbago, sponsored by Shahrekord University of Medical Sciences. Primary endpoint: Pain intensity reduction. Started Mar 2013; status: completed.

02

Drugs

gabapentin
03

Conditions

acute lumbago

Beyond the preview

Go deeper on IRCT201303096480N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201303096480N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call